Valirx Plc (VALX)

London
18.3350
-0.1650(-0.89%)
  • Volume:
    97,304
  • Bid/Ask:
    18.0000/19.0000
  • Day's Range:
    18.0000 - 19.0000

VALX Overview

Prev. Close
18.5
Day's Range
18-19
Revenue
-
Open
18.75
52 wk Range
7-73
EPS
-0.06
Volume
97,304
Market Cap
11.93M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
588,789
P/E Ratio
-
Beta
3.12
1-Year Change
65.08%
Shares Outstanding
65,049,156
Next Earnings Date
-
What is your sentiment on Valirx Plc?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellStrong Sell
Technical IndicatorsSellNeutralBuyStrong SellBuy
SummaryNeutralNeutralNeutralStrong SellNeutral

Valirx Plc Company Profile

Valirx Plc Company Profile

Employees
11

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company’s lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc has collaboration agreement with Oncolytika Limited and Black Cat Bio Limited to develop and evaluate VAL201 for patients suffering a hyperimmune response to Coronavirus SARS-CoV2 infection. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.

Read More
  • About what?
    2
    • any news?
      0
      • Does anyone think ValiRx can ever recover to its formwr glory days? Even anything over £1??
        0
        • https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
          0
          • check out Aim Listed DeepMatter Ltd
            0
            • shite
              0
          • high risk high reward
            0
            • A train wreck in progress here...massive dilution time and again.
              2
              • This didn't age well.
                0
            • Please correct the bid/ask price. It’s been incorrect for weeks. Thanks
              0
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.